Skip to main content

Table 1 Characteristics of included studies

From: Is there a relationship between psoriasis and hepatitis C? A meta-analysis and bioinformatics investigation

Source Study location Study Design Case Group Control Group OR (95% CI)
Psoriasis cases Hepatitis C cases (%) Control cases Hepatitis C cases (%)
Chouela et al. [22] Argentina Cross-sectional 118 (75 men, 43 women) patients with psoriasis 9/118 (7.6%) 60,000 blood donors 720/60000 (1.2%) 6.79 (3.43–13.46)
Carlo et al. [23] Italy Case–control 100 patients with psoriatic arthritis 1/100 (1%) 100 patients with from peripheral osteoarthritis (OA) or sciatica due to L4 L5 or L5 S1 herniated disc (two HCV unrelated disorders 4/100 (4%) 0.24 (0.117–0.492)
Arnon et al. [24] Israel Case–control 12,502 psoriasis patients 129/12502 (1.03%) 24,287 age- and sex- matched controls 135/24287 (0.56%) 1.86 (1.46–2.38)
Tsai et al. [25] Taiwan Case–control 51,800 Patients with psoriasis (31 923 males and 19,877 females) 184/51800 (0.36%) 207,200 Controls matched for age, sex, and urbanization level of residential area 404/207200 (0.19%) 2.02 (1.67–2.43)
Andrade et al. [26] Brasil Cross-sectional 140 patients with psoriasis 10/140 (7.1%) 2,675,000 people in the city of Salvador 40,125/2675000 (1.5%) 5.05 (2.655–9.611)
Kanada et al. [27] US Cross-sectional 148 patients with psoriasis 1/148 (0.6%) 5717 Non-psoriasis 125/5717 (2.2%) 0.24 (0.03–2.01)
Brazzelli et al. [28] Italy Cross-sectional 168 patients with psoriasis 14/168 (7.7%) 6917 people from northern Italian towns 221/6917 (3.2%) 2.75 (1.57–4.83)
Shinichi et al. [29] Japan Cross-sectional 717 (482 men, 235 women) patients with psoriasis 54/717 (7.5%) 38,057 (17,926 men and 20,131 women) patients with other dermatological diseases 1239/38057 (3.3%) 2.42 (1.82–3.21)
Randa et al. [30] Egypt Cross-sectional 100 Patients with psoriasis 19/100 (19%) 200 healthy volunteers 17/200 (8.5%) 1.14 (0.56–2.35)
Orrell et al. [31] US Cross-sectional 2590 people with psoriasis 34/2590 (1.3%) 112,265 people without psoriasis 1830/112265 (1.6%) 0.8 (0.57–1.13)
Noe et al. [32] UK Cross-sectional 188,664 Patients with mild psoriasis 320/188664 (0.17%) 961,888 matched controls 1154/961888 (0.12%) 1.88 (1.10–3.51)